TURBINE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TURBINE Trademark

Serial Number: 79297909 • Registration: 6541641

TURBINE is a trademark filed by Turbine Simulated Cell Technologies Ltd on June 4, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Turbine Simulated Cell Technologies Ltd (2 trademarks)

6th Floor One London Wall

Entity Type: 99

Trademark Details

Filing Date

June 4, 2020

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Downloadable cloud based computer software for molecular biology and medicinal chemistry research; Downloadable cloud based bioinformatics software for molecular biology and medicinal chemistry research; Downloadable cloud based computer software platforms for molecular biology and medicinal chemistry research; scientific apparatus for measuring and analysing scientific data; data analysis apparatus incorporating computer software; Downloadable cloud based data analysis software for molecular biology and medicinal chemistry research; Downloadable cloud based computer software artificial intelligence platforms for machine learning; Downloadable cloud based databases in the field of molecular biology and medicinal chemistry research; Downloadable cloud based computer software for creating biological simulations; Downloadable cloud based computer computational simulation and modelling software; Downloadable cloud based computer software for storing and processing biological data; Downloadable cloud based computer computational biomodelling software; Downloadable cloud based computer software for developing algorithms and models of biological systems and relationships; Downloadable cloud based computer software for computational biology; Downloadable cloud based computer software for biological cell modelling

Medical and veterinary preparations for therapeutic purposes for the treatment of cancer; therapeutic preparations for cell treatment; preparations for modifying human and animal cells for medical and therapeutic purposes; biological, chemical and biochemical reagents and assays for medical research use being the testing of body compositions

Reagents and assays for molecular biology and medicinal chemistry research purposes; biological preparations for use in industry and science; chemical and biochemical reagents and assays for molecular biology and medicinal chemistry research use

Scientific and technological research and design in the field of molecular biology and medicinal chemistry; scientific and technological services and research and design relating thereto, namely, providing non-downloadable computer software for molecular biology and medicinal chemistry research, non-downloadable computer software for molecular biology and medicinal chemistry research, non-downloadable bioinformatics software for molecular biology and medicinal chemistry research, non-downloadable computer software platforms for molecular biology and medicinal chemistry research, non-downloadable data analysis software for molecular biology and medicinal chemistry research, non-downloadable computer software artificial intelligence platforms for machine learning, non-downloadable databases in the field of molecular biology and medicinal chemistry research, non-downloadable computer software for creating biological simulations, non-downloadable computer computational simulation and modelling software, non-downloadable computer software for storing and processing biological data, non-downloadable computer computational biomodelling software, non-downloadable computer software for developing algorithms and models of biological systems, non-downloadable computer software for computational biology and non-downloadable computer software for biological cell modelling; scientific research in human and animal biological systems; design and development of new products, namely, molecular biology and medicinal chemistry simulation software for internal use; scientific laboratory services; computational biology services; computational cell modelling services; Scientific and technological services, namely, analyzing scientific and technical data in the fields of molecular biology and medicinal chemistry; development of computer programs for simulating laboratory experiments; bioinformatics services; scientific research featuring computational biomodeling services; providing online non-downloadable software platforms incorporating artificial intelligence; software as a services (SaaS) featuring software for machine learning in the fields of molecular biology and medicinal chemistry; hosting computer application software in the field of knowledge management for creating searchable databases of information and data; software as a service in the field of biological simulations and computational biology and biomodelling; scientific research services, namely, running biological simulations for others; scientific research services, namely, developing algorithms and models of biological systems and relationships; advisory and consultancy relating to all the aforesaid services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 8, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 15, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 22, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 2, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 9, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 9, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 9, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 21, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 19, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 18, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 12, 2020 REPR